LH Stock Analysis: Buy, Sell, or Hold?
LH - Labcorp Holdings Inc.
$309.20
-6.33 (-2.01%)
▼
5d:
+4.19%
30d:
+8.92%
90d:
+20.4%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When LH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LH is fairly valued with market pricing in 3.6% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: LH is fairly valued with market pricing in 3.6% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$363.75
Based on 5.5% avg growth
INTRINSIC VALUE TODAY
$225.86
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LH is currently trading at $309.20, which is considered extended relative to its 30-day fair value range of $268.05 to $296.58. From a valuation perspective, the stock is trading at a premium (Forward PE: 15.9) compared to its historical average (14.3). At these levels, the market is pricing in 3.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LH is in a uptrend. The price is approaching resistance at $316.11. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LH is in a uptrend. The price is approaching resistance at $316.11. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$268.05 -
$296.58
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
58.1%
Protect Your Profits
Holding LH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($315.62)
- NEUTRAL: Market pricing in 3.6% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$268.05 -
$296.58
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$277.04
Resistance Level
$316.11
Current Trend
Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.88
Wall Street Target
$315.63
(+2.1%)
Revenue Growth (YoY)
5.8%
Earnings Growth (YoY)
32.9%
Profit Margin
6.7%
Valuation Premium vs History
+3.6% premium
PE vs Historical
15.9 vs 14.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.6%
(market-implied from PE analysis)
1-Year Target
$320.33
(+4%)
2-Year Target
$331.86
(+7%)
3-Year Target
$343.81
(+11%)
3-Yr Target (if PE normalizes)
(PE: 16→14)
PE COMPRESSION
$309.55
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 7.0%)
$494.93
(+60%)
Base:
(SPY PE: 15.9, Growth: 7.0%)
$379.20
(+23%)
Bear:
(PE: 13.5, Growth: 7.0%)
$322.32
(+4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 26.12 | Current EPS (TTM): $12.08
Bull Case
$559.35
(+81%)
Analyst growth 61.2%, PE expands to 28.7
Base Case
$508.50
(+65%)
Market implied 61.2%, PE stable at 26.1
Bear Case
$214.56
(-31%)
Severe decline -20.0%, PE contracts to 22.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 7:50 PM ET
Data refreshes hourly during market hours. Next update: 8:50 PM
Data refreshes hourly during market hours. Next update: 8:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LH showing a specific setup today?
Insider Activity (6 Months)
2
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Adam H Schechter
SELL
8705 shares
2026-03-03
Der Vaart Sandra D Van
SELL
548 shares
2026-02-27
Brian J Caveney
SELL
1500 shares
2026-02-24
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$630 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$188 | 61 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 59 HOLD |
Advanced LH Option Strategies
Professional options setups generated by AI based on today's LH price and gamma walls.
